THB 19.60+THB 0.00 (0.0%)
Bangkok Dusit Medical Services Public Company Limited’s quoted price sits in the lower half of its reported 52-week range, 12.5% below the high.
Loading market information…
SET · BIZ.BK · THB
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 09:37 AM UTC. Cached market data; not a live quote.
One-year closing-price history · THB. Historical prices are not a forecast.
Business Alignment Public Company Limited’s quoted price sits in the upper half of its reported 52-week range, 7.69% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Business Alignment Public Company Limited’s forward annual dividend is THB 0.50 per share, paid annual. The forward yield is 8.33% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Business Alignment Public Company Limited’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Established in Bangkok, Thailand, in 2000, Business Alignment Public Company Limited is primarily engaged in the provision and setup of specialized medical equipment and software systems for radiotherapy-based cancer treatment throughout Thailand. Its services also encompass the construction of facilities designed to house these medical devices, as well as comprehensive repair and maintenance for them. Furthermore, the company manages and operates its own hospital dedicated exclusively to cancer care.
Latest available per-share figures in THB. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 12:45 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
THB 19.60+THB 0.00 (0.0%)
Bangkok Dusit Medical Services Public Company Limited’s quoted price sits in the lower half of its reported 52-week range, 12.5% below the high.
THB 203.00+THB 6.50 (+3.31%)
Bumrungrad Hospital Public Company Limited’s quoted price sits in the upper half of its reported 52-week range, 5.14% below the high.
THB 33.00+THB 0.25 (+0.76%)
Mega Lifesciences Public Company Limited’s quoted price sits in the lower half of its reported 52-week range, 17.5% below the high.
THB 10.80-THB 0.10 (-0.92%)
Bangkok Chain Hospital Public Company Limited’s quoted price sits in the upper half of its reported 52-week range, 10.74% below the high.
THB 17.10-THB 0.20 (-1.16%)
Ramkhamhaeng Hospital Public Company Limited’s quoted price sits in the lower half of its reported 52-week range, 10.0% below the high.
THB 0.11+THB 0.01 (+10.0%)
E for L Aim Public Company Limited’s quoted price sits in the lower half of its reported 52-week range, 35.29% below the high.
THB 1.15-THB 0.04 (-3.36%)
Techno Medical Public Company Limited’s quoted price sits in the upper half of its reported 52-week range, 23.33% below the high.
THB 1.53-THB 0.06 (-3.77%)
SMD Rise Public Company Limited’s quoted price sits in the lower half of its reported 52-week range, 49.0% below the high.